Insider

Amit Sachdev Insider Trading Activity

Every SEC Form 4 transaction reported by Amit Sachdev, sourced directly from SEC EDGAR and updated as new filings are accepted.

By · Insider-trading data from SEC EDGAR
Latest filing:

Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.

Quick Answer

Is Amit Sachdev buying or selling?

Amit Sachdev reported 0 open-market buys ($0) and 50 sells ($105.3M) across 50 Form 4 filings at 1 company — a net selling position of $105.3M.

Source: SEC EDGAR Form 4

What stands out

Key Statistics (as of Feb 26, 2026)

Total Form 4 filings
50
SEC EDGAR
Companies
1
Buys (0)
$0
Sells (50)
$105.3M

Insider sentiment

Net selling

Net insider flow of $105.3M in net selling, filed between Jan 23, 2018 – Feb 26, 2026.

Companies Amit Sachdev files for

#CompanyForm 4 filings
1VRTXVERTEX PHARMACEUTICALS INC / MA50

Recent Amit Sachdev transactions

DateTickerRoleTypeSharesValueFiling
Feb 26, 2026VRTXEVP Chief Patient & Ext Af OffSale1.8K$897.8KSEC ↗
Feb 23, 2026VRTXEVP Chief Patient & Ext Af OffSale58.6K$27.5MSEC ↗
May 17, 2024VRTXEVP Chief Patient & Ext Af OffSale32$13.8KSEC ↗
Feb 27, 2024VRTXEVP Chief Patient & Ext Af OffSale3.0K$1.3MSEC ↗
Feb 23, 2024VRTXEVP Chief Patient & Ext Af OffSale3.2K$1.3MSEC ↗
Feb 21, 2024VRTXEVP Chief Patient & Ext Af OffSale4.3K$1.8MSEC ↗
Feb 13, 2024VRTXEVP Chief Patient & Ext Af OffSale3.2K$1.4MSEC ↗
Nov 17, 2023VRTXEVP Chief Patient & Ext Af OffSale35$12.9KSEC ↗
Aug 14, 2023VRTXEVP, Chief Patient OfficerSale10.0K$3.5MSEC ↗
Nov 16, 2021VRTXEVP, Chief Patient OfficerSale51$9.5KSEC ↗
May 19, 2021VRTXEVP, Chief Patient OfficerSale45$9.7KSEC ↗
Apr 29, 2021VRTXEVP, Chief Patient OfficerSale3.9K$839.2KSEC ↗
Feb 26, 2021VRTXEVP, Chief Patient OfficerSale3.6K$765.3KSEC ↗
Feb 19, 2021VRTXEVP, Chief Patient OfficerSale9.3K$2.0MSEC ↗
Feb 16, 2021VRTXEVP, Chief Patient OfficerSale4.5K$939.1KSEC ↗
Nov 18, 2020VRTXEVP, Chief Patient OfficerSale42$9.4KSEC ↗
Aug 5, 2020VRTXEVP, Chief Patient OfficerSale1.9K$540.1KSEC ↗
May 19, 2020VRTXEVP, Chief Patient OfficerSale58$16.5KSEC ↗
May 13, 2020VRTXEVP, Chief Patient OfficerSale10.7K$3.0MSEC ↗
May 8, 2020VRTXEVP, Chief Patient OfficerSale669$184.2KSEC ↗
May 6, 2020VRTXEVP, Chief Patient OfficerSale57.1K$15.1MSEC ↗
Feb 26, 2020VRTXEVP, Chief Patient OfficerSale3.4K$788.4KSEC ↗
Feb 19, 2020VRTXEVP, Chief Patient OfficerSale3.5K$849.8KSEC ↗
Feb 12, 2020VRTXEVP, Chief Patient OfficerSale13.1K$3.2MSEC ↗
Feb 5, 2020VRTXEVP, Chief Patient OfficerSale4.1K$946.8KSEC ↗

Showing the 25 most recent filings of 50. Screen every filing.

Amit Sachdev insider trading FAQ

Is Amit Sachdev buying or selling?

Across 50 SEC Form 4 filings, Amit Sachdev reported 0 open-market purchases totaling $0 and 50 sales totaling $105.3M — a net selling position of $105.3M.

Which companies does Amit Sachdev file Form 4s for?

Amit Sachdev has reported insider transactions at 1 company, most often VERTEX PHARMACEUTICALS INC / MA (VRTX).

How far back does Amit Sachdev's filing history go?

Trabud holds Amit Sachdev's SEC Form 4 filings from Jan 23, 2018 – Feb 26, 2026, sourced directly from SEC EDGAR.

Where does Trabud get Amit Sachdev's insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Learn

What is SEC Form 4?

The filing behind every transaction here

Guide

How to Track Insider Trading

A practical workflow for following Form 4 activity

Use Case

Insider Buying Signals

How investors read insider purchases

Track Amit Sachdev and every other insider

Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.

Open the screener